CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $822 | -86.9% | 637 | -82.5% | 0.00% | – |
| Q2 2023 | $6,252 | +264.8% | 3,635 | +220.3% | 0.00% | – |
| Q1 2023 | $1,714 | +445.9% | 1,135 | +479.1% | 0.00% | – |
| Q4 2022 | $314 | – | 196 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 196 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 196 | -60.5% | 0.00% | – |
| Q1 2022 | $1,000 | -85.7% | 496 | -67.2% | 0.00% | – |
| Q4 2021 | $7,000 | -36.4% | 1,511 | -16.1% | 0.00% | – |
| Q2 2021 | $11,000 | +22.2% | 1,800 | +63.6% | 0.00% | – |
| Q1 2021 | $9,000 | +50.0% | 1,100 | +266.7% | 0.00% | – |
| Q4 2017 | $6,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,803,700 | $25,130,000 | 0.91% |
| Altium Capital Management LP | 663,800 | $2,874,000 | 0.79% |
| Rubric Capital Management LP | 2,406,449 | $10,420,000 | 0.49% |
| RTW INVESTMENTS, LP | 6,029,700 | $26,109,000 | 0.38% |
| Orbimed Advisors | 3,214,509 | $13,919,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 152,345 | $660,000 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 980,085 | $4,244,000 | 0.12% |
| Point72 Asset Management, L.P. | 6,303,025 | $27,292,000 | 0.11% |
| Sender Co & Partners, Inc. | 40,720 | $176,000 | 0.09% |
| Manteio Capital LLC | 15,067 | $65,000 | 0.08% |